2022
DOI: 10.1084/jem.20211121
|View full text |Cite
|
Sign up to set email alerts
|

DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes

Abstract: Aberrant induction of type I IFN is a hallmark of the inherited encephalopathy Aicardi-Goutières syndrome (AGS), but the mechanisms triggering disease in the human central nervous system (CNS) remain elusive. Here, we generated human models of AGS using genetically modified and patient-derived pluripotent stem cells harboring TREX1 or RNASEH2B loss-of-function alleles. Genome-wide transcriptomic analysis reveals that spontaneous proinflammatory activation in AGS astrocytes initiates signaling cascades impactin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
28
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(31 citation statements)
references
References 131 publications
(190 reference statements)
3
28
0
Order By: Relevance
“…The mechanisms driving cGAS/STING activation in our AAPV model may be multiple and remain to be further investigated. “Misplaced” cytosolic self-DNA in stressed cells is known to efficiently activate cGAS resulting in IFN-I release ( West et al, 2015 ; Giordano et al, 2022 ), which may contribute to cGAS activation during AAPV progression. On the other hand, extracellular DNA is known to reach the cytosol and activate cGAS/STING in vivo under some conditions ( Gehrke et al, 2013 ).…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms driving cGAS/STING activation in our AAPV model may be multiple and remain to be further investigated. “Misplaced” cytosolic self-DNA in stressed cells is known to efficiently activate cGAS resulting in IFN-I release ( West et al, 2015 ; Giordano et al, 2022 ), which may contribute to cGAS activation during AAPV progression. On the other hand, extracellular DNA is known to reach the cytosol and activate cGAS/STING in vivo under some conditions ( Gehrke et al, 2013 ).…”
Section: Discussionmentioning
confidence: 99%
“…It is currently discussed if the SARS-CoV-2 pandemic will lead to a second pandemic of neurodegenerative diseases in the next years but further studies are needed to investigate the direct link of viral induced systemic inflammation and its effects on myelination, synapse organization and neurodegeneration and to correlate the clinically observed neurological symptoms and changes in cognition due to SARS-CoV-2 infection as well as other virus induced or autoimmune/autoinflammatory disorders. Along this line, certain "interferonopathies'' such as Aicardi-Goutières syndrome and SLE are associated with neurological symptoms and cognitive impairment [110][111][112] and studies in mice suggest a detrimental collateral damage of the CNS in the context of a systemic type I Interferon response in certain viral infections [113][114][115][116] . In mice, also chronic presence of IFN-I in the brain alone could negatively affect cognitive function, mediated via modulation of microglial activity 117 .…”
Section: Discussionmentioning
confidence: 99%
“…3A) suggesting that STING signaling is not crucial in controlling the growth of Samhd1 Δ/Δ Trp53 -/- -deficient tumors. We and others previously reported that loss of p53 increased DNA damage and potentiated the spontaneous cGAS/STING-dependent IFN response in mice (Hiller et al, 2018) and in iPSCs (Giordano et al, 2022) with a defect in the essential DNA repair enzyme RNaseH2, strongly implicating genome damage in the generation of immune stimulatory DNA in this model. To better understand the lack of an effect of STING-deficiency in our Samhd1 Δ/Δ Trp53 -/- mouse model, we quantified the spontaneous activation of the type I IFN system.…”
Section: Resultsmentioning
confidence: 59%
“…We recently reported evidence that the IFN response in Trex1 -/- mice is linked to DNA replication (Schubert et al, 2022) and similar findings have been reported for SAMHD1 -/- cells (Coquel et al, 2018). In both models, loss of p53 did not amplify the IFN response, while such p53-dependent amplification was observed in cells lacking RNaseH2, in which chromatin fragments activate cGAS (Hiller et al, 2018; Mackenzie et al, 2017; Giordano et al, 2022). This points to a differential involvement of the p53 pathway in the generation of immune stimulatory DNA as a result of DNA replication in cells lacking TREX1 or SAMHD1 compared with post-replicative DNA damage found in RNaseH2-deficient cells.…”
Section: Discussionmentioning
confidence: 91%